Publisher
Springer International Publishing
Reference16 articles.
1. Cattran DC. Idiopathic membranous glomerulonephritis. Kidney Int. 2001;59(5):1983–94.
2. Taylor DM, Cameron PA, Eddey D. Recurrent overdose: patient characteristics, habits, and outcomes. J Accid Emerg Med. 1998;15(4):257–61.
3. Ponticelli C, Passerini P. Can prognostic factors assist therapeutic decisions in idiopathic membranous nephropathy? J Nephrol. 2010;23(2):156–63.
4. Ponticelli C, Passerini P. Management of idiopathic membranous nephropathy. Expert Opin Pharmacother. 2010;11(13):2163–75.
5. Dahan K, Debiec H, Plaisier E, Cachanado M, Rousseau A, Wakselman L, et al. Rituximab for severe membranous nephropathy: a 6-month trial with extended follow-up. J Am Soc Nephrol. 2017;28(1):348–58.